Covid-19 Impact on Imatinib Mesylate Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Imatinib Mesylate, including the following market information:
Major competitors identified in this market include GLEEVEC, Cayman Chemical, Sichuan Xieli, Nanjing Kaihua Chemical, Zhengda Tianqing, etc.
Based on the Region:
- Global Imatinib Mesylate Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
- Global Imatinib Mesylate Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
- Global Imatinib Mesylate Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
- Global Imatinib Mesylate Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)
Major competitors identified in this market include GLEEVEC, Cayman Chemical, Sichuan Xieli, Nanjing Kaihua Chemical, Zhengda Tianqing, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- 99% Purity
- 98% Purity
- Other
- CML
- GIST
- Other
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Imatinib Mesylate Industry
1.7 COVID-19 Impact: Imatinib Mesylate Market Trends
2 GLOBAL IMATINIB MESYLATE QUARTERLY MARKET SIZE ANALYSIS
2.1 Imatinib Mesylate Business Impact Assessment - COVID-19
2.1.1 Global Imatinib Mesylate Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Imatinib Mesylate Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Imatinib Mesylate Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Imatinib Mesylate Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Imatinib Mesylate Factory Price by Manufacturers
3.3 Location of Key Manufacturers Imatinib Mesylate Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Imatinib Mesylate Market
3.5 Key Manufacturers Imatinib Mesylate Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON IMATINIB MESYLATE SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 99% Purity
1.4.2 98% Purity
1.4.3 Other
4.2 By Type, Global Imatinib Mesylate Market Size, 2019-2021
4.2.1 By Type, Global Imatinib Mesylate Market Size by Type, 2020-2021
4.2.2 By Type, Global Imatinib Mesylate Price, 2020-2021
5 IMPACT OF COVID-19 ON IMATINIB MESYLATE SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 CML
5.5.2 GIST
5.5.3 Other
5.2 By Application, Global Imatinib Mesylate Market Size, 2019-2021
5.2.1 By Application, Global Imatinib Mesylate Market Size by Application, 2019-2021
5.2.2 By Application, Global Imatinib Mesylate Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 GLEEVEC
7.1.1 GLEEVEC Business Overview
7.1.2 GLEEVEC Imatinib Mesylate Quarterly Production and Revenue, 2020
7.1.3 GLEEVEC Imatinib Mesylate Product Introduction
7.1.4 GLEEVEC Response to COVID-19 and Related Developments
7.2 Cayman Chemical
7.2.1 Cayman Chemical Business Overview
7.2.2 Cayman Chemical Imatinib Mesylate Quarterly Production and Revenue, 2020
7.2.3 Cayman Chemical Imatinib Mesylate Product Introduction
7.2.4 Cayman Chemical Response to COVID-19 and Related Developments
7.3 Sichuan Xieli
7.3.1 Sichuan Xieli Business Overview
7.3.2 Sichuan Xieli Imatinib Mesylate Quarterly Production and Revenue, 2020
7.3.3 Sichuan Xieli Imatinib Mesylate Product Introduction
7.3.4 Sichuan Xieli Response to COVID-19 and Related Developments
7.4 Nanjing Kaihua Chemical
7.4.1 Nanjing Kaihua Chemical Business Overview
7.4.2 Nanjing Kaihua Chemical Imatinib Mesylate Quarterly Production and Revenue, 2020
7.4.3 Nanjing Kaihua Chemical Imatinib Mesylate Product Introduction
7.4.4 Nanjing Kaihua Chemical Response to COVID-19 and Related Developments
7.5 Zhengda Tianqing
7.5.1 Zhengda Tianqing Business Overview
7.5.2 Zhengda Tianqing Imatinib Mesylate Quarterly Production and Revenue, 2020
7.5.3 Zhengda Tianqing Imatinib Mesylate Product Introduction
7.5.4 Zhengda Tianqing Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Imatinib Mesylate Supply Chain Analysis
8.1.1 Imatinib Mesylate Supply Chain Analysis
8.1.2 Covid-19 Impact on Imatinib Mesylate Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Imatinib Mesylate Distribution Channels
8.2.2 Covid-19 Impact on Imatinib Mesylate Distribution Channels
8.2.3 Imatinib Mesylate Distributors
8.3 Imatinib Mesylate Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Imatinib Mesylate Industry
1.7 COVID-19 Impact: Imatinib Mesylate Market Trends
2 GLOBAL IMATINIB MESYLATE QUARTERLY MARKET SIZE ANALYSIS
2.1 Imatinib Mesylate Business Impact Assessment - COVID-19
2.1.1 Global Imatinib Mesylate Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Imatinib Mesylate Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Imatinib Mesylate Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Imatinib Mesylate Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Imatinib Mesylate Factory Price by Manufacturers
3.3 Location of Key Manufacturers Imatinib Mesylate Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Imatinib Mesylate Market
3.5 Key Manufacturers Imatinib Mesylate Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON IMATINIB MESYLATE SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 99% Purity
1.4.2 98% Purity
1.4.3 Other
4.2 By Type, Global Imatinib Mesylate Market Size, 2019-2021
4.2.1 By Type, Global Imatinib Mesylate Market Size by Type, 2020-2021
4.2.2 By Type, Global Imatinib Mesylate Price, 2020-2021
5 IMPACT OF COVID-19 ON IMATINIB MESYLATE SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 CML
5.5.2 GIST
5.5.3 Other
5.2 By Application, Global Imatinib Mesylate Market Size, 2019-2021
5.2.1 By Application, Global Imatinib Mesylate Market Size by Application, 2019-2021
5.2.2 By Application, Global Imatinib Mesylate Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 GLEEVEC
7.1.1 GLEEVEC Business Overview
7.1.2 GLEEVEC Imatinib Mesylate Quarterly Production and Revenue, 2020
7.1.3 GLEEVEC Imatinib Mesylate Product Introduction
7.1.4 GLEEVEC Response to COVID-19 and Related Developments
7.2 Cayman Chemical
7.2.1 Cayman Chemical Business Overview
7.2.2 Cayman Chemical Imatinib Mesylate Quarterly Production and Revenue, 2020
7.2.3 Cayman Chemical Imatinib Mesylate Product Introduction
7.2.4 Cayman Chemical Response to COVID-19 and Related Developments
7.3 Sichuan Xieli
7.3.1 Sichuan Xieli Business Overview
7.3.2 Sichuan Xieli Imatinib Mesylate Quarterly Production and Revenue, 2020
7.3.3 Sichuan Xieli Imatinib Mesylate Product Introduction
7.3.4 Sichuan Xieli Response to COVID-19 and Related Developments
7.4 Nanjing Kaihua Chemical
7.4.1 Nanjing Kaihua Chemical Business Overview
7.4.2 Nanjing Kaihua Chemical Imatinib Mesylate Quarterly Production and Revenue, 2020
7.4.3 Nanjing Kaihua Chemical Imatinib Mesylate Product Introduction
7.4.4 Nanjing Kaihua Chemical Response to COVID-19 and Related Developments
7.5 Zhengda Tianqing
7.5.1 Zhengda Tianqing Business Overview
7.5.2 Zhengda Tianqing Imatinib Mesylate Quarterly Production and Revenue, 2020
7.5.3 Zhengda Tianqing Imatinib Mesylate Product Introduction
7.5.4 Zhengda Tianqing Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Imatinib Mesylate Supply Chain Analysis
8.1.1 Imatinib Mesylate Supply Chain Analysis
8.1.2 Covid-19 Impact on Imatinib Mesylate Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Imatinib Mesylate Distribution Channels
8.2.2 Covid-19 Impact on Imatinib Mesylate Distribution Channels
8.2.3 Imatinib Mesylate Distributors
8.3 Imatinib Mesylate Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Imatinib Mesylate Assessment
Table 9. COVID-19 Impact: Imatinib Mesylate Market Trends
Table 10. COVID-19 Impact Global Imatinib Mesylate Market Size
Table 11. Global Imatinib Mesylate Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (MT)
Table 12. Global Imatinib Mesylate Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Imatinib Mesylate Quarterly Market Size, 2020 (US$ Million) & (MT)
Table 14. Global Imatinib Mesylate Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Imatinib Mesylate Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (MT)
Table 16. Global Imatinib Mesylate Market Growth Drivers
Table 17. Global Imatinib Mesylate Market Restraints
Table 18. Global Imatinib Mesylate Market Opportunities
Table 19. Global Imatinib Mesylate Market Challenges
Table 20. Key Manufacturers Imatinib Mesylate Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Imatinib Mesylate Market Size, 2019 (MT) & (US$ Million)
Table 22. Imatinib Mesylate Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Imatinib Mesylate Manufacturing Plants
Table 24. Key Manufacturers Imatinib Mesylate Market Served
Table 25. Date of Key Manufacturers Enter into Imatinib Mesylate Market
Table 26. Key Manufacturers Imatinib Mesylate Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Imatinib Mesylate Market Size by Type, 2020, (US$ Million)
Table 29. Global Imatinib Mesylate Market Size by Type, 2020 (MT)
Table 30. Global Imatinib Mesylate Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Imatinib Mesylate Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Imatinib Mesylate Market Size by Application, 2020-2021 (MT)
Table 33. Global Imatinib Mesylate Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Imatinib Mesylate Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Imatinib Mesylate Market Size by Region, 2019-2021 (MT)
Table 36. By Country, North America Imatinib Mesylate Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Imatinib Mesylate Market Size, 2019-2021 (MT)
Table 38. US Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 39. Canada Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Imatinib Mesylate Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Imatinib Mesylate Market Size, 2019-2021 (MT)
Table 43. Germany Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 44. France Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 45. UK Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 46. Italy Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Imatinib Mesylate Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Imatinib Mesylate Market Size, 2019-2021 (MT)
Table 50. China Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 51. Japan Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 52. South Korea Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 53. India Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 54. ASEAN Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 55. Latin America Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 56. Middle East and Africa Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 57. GLEEVEC Business Overview
Table 58. GLEEVEC Imatinib Mesylate Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. GLEEVEC Imatinib Mesylate Product
Table 60. GLEEVEC Response to COVID-19 and Related Developments
Table 61. Cayman Chemical Business Overview
Table 62. Cayman Chemical Imatinib Mesylate Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Cayman Chemical Imatinib Mesylate Product
Table 64. Cayman Chemical Response to COVID-19 and Related Developments
Table 65. Sichuan Xieli Business Overview
Table 66. Sichuan Xieli Imatinib Mesylate Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Sichuan Xieli Imatinib Mesylate Product
Table 68. Sichuan Xieli Response to COVID-19 and Related Developments
Table 69. Nanjing Kaihua Chemical Business Overview
Table 70. Nanjing Kaihua Chemical Imatinib Mesylate Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Nanjing Kaihua Chemical Imatinib Mesylate Product
Table 72. Nanjing Kaihua Chemical Response to COVID-19 and Related Developments
Table 73. Zhengda Tianqing Business Overview
Table 74. Zhengda Tianqing Imatinib Mesylate Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Zhengda Tianqing Imatinib Mesylate Product
Table 76. Zhengda Tianqing Response to COVID-19 and Related Developments
Table 77. Imatinib Mesylate Distributors List
Table 78. Imatinib Mesylate Customers List
Table 79. Covid-19 Impact on Imatinib Mesylate Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Imatinib Mesylate Assessment
Table 9. COVID-19 Impact: Imatinib Mesylate Market Trends
Table 10. COVID-19 Impact Global Imatinib Mesylate Market Size
Table 11. Global Imatinib Mesylate Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (MT)
Table 12. Global Imatinib Mesylate Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)
Table 13. Global Imatinib Mesylate Quarterly Market Size, 2020 (US$ Million) & (MT)
Table 14. Global Imatinib Mesylate Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Imatinib Mesylate Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (MT)
Table 16. Global Imatinib Mesylate Market Growth Drivers
Table 17. Global Imatinib Mesylate Market Restraints
Table 18. Global Imatinib Mesylate Market Opportunities
Table 19. Global Imatinib Mesylate Market Challenges
Table 20. Key Manufacturers Imatinib Mesylate Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Imatinib Mesylate Market Size, 2019 (MT) & (US$ Million)
Table 22. Imatinib Mesylate Factory Price by Manufacturers 2020 (USD/MT)
Table 23. Location of Key Manufacturers Imatinib Mesylate Manufacturing Plants
Table 24. Key Manufacturers Imatinib Mesylate Market Served
Table 25. Date of Key Manufacturers Enter into Imatinib Mesylate Market
Table 26. Key Manufacturers Imatinib Mesylate Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Imatinib Mesylate Market Size by Type, 2020, (US$ Million)
Table 29. Global Imatinib Mesylate Market Size by Type, 2020 (MT)
Table 30. Global Imatinib Mesylate Price: by Type, 2020-2021 (USD/MT)
Table 31. Global Imatinib Mesylate Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Imatinib Mesylate Market Size by Application, 2020-2021 (MT)
Table 33. Global Imatinib Mesylate Price: by Application, 2020-2021 (USD/MT)
Table 34. Global Imatinib Mesylate Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Imatinib Mesylate Market Size by Region, 2019-2021 (MT)
Table 36. By Country, North America Imatinib Mesylate Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Imatinib Mesylate Market Size, 2019-2021 (MT)
Table 38. US Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 39. Canada Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Imatinib Mesylate Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Imatinib Mesylate Market Size, 2019-2021 (MT)
Table 43. Germany Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 44. France Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 45. UK Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 46. Italy Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Imatinib Mesylate Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Imatinib Mesylate Market Size, 2019-2021 (MT)
Table 50. China Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 51. Japan Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 52. South Korea Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 53. India Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 54. ASEAN Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 55. Latin America Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 56. Middle East and Africa Imatinib Mesylate Market Size, 2019-2021 (US$ Million) & (MT)
Table 57. GLEEVEC Business Overview
Table 58. GLEEVEC Imatinib Mesylate Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. GLEEVEC Imatinib Mesylate Product
Table 60. GLEEVEC Response to COVID-19 and Related Developments
Table 61. Cayman Chemical Business Overview
Table 62. Cayman Chemical Imatinib Mesylate Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Cayman Chemical Imatinib Mesylate Product
Table 64. Cayman Chemical Response to COVID-19 and Related Developments
Table 65. Sichuan Xieli Business Overview
Table 66. Sichuan Xieli Imatinib Mesylate Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Sichuan Xieli Imatinib Mesylate Product
Table 68. Sichuan Xieli Response to COVID-19 and Related Developments
Table 69. Nanjing Kaihua Chemical Business Overview
Table 70. Nanjing Kaihua Chemical Imatinib Mesylate Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Nanjing Kaihua Chemical Imatinib Mesylate Product
Table 72. Nanjing Kaihua Chemical Response to COVID-19 and Related Developments
Table 73. Zhengda Tianqing Business Overview
Table 74. Zhengda Tianqing Imatinib Mesylate Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Zhengda Tianqing Imatinib Mesylate Product
Table 76. Zhengda Tianqing Response to COVID-19 and Related Developments
Table 77. Imatinib Mesylate Distributors List
Table 78. Imatinib Mesylate Customers List
Table 79. Covid-19 Impact on Imatinib Mesylate Customers
LIST OF FIGURES
Figure 1. Imatinib Mesylate Product Picture
Figure 2. Imatinib Mesylate Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Imatinib Mesylate Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Imatinib Mesylate Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Imatinib Mesylate Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Imatinib Mesylate Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Imatinib Mesylate Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Imatinib Mesylate Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Imatinib Mesylate Market Size Market Share, 2019-2021
Figure 1. Imatinib Mesylate Product Picture
Figure 2. Imatinib Mesylate Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Imatinib Mesylate Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Imatinib Mesylate Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Imatinib Mesylate Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Imatinib Mesylate Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Imatinib Mesylate Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Imatinib Mesylate Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Imatinib Mesylate Market Size Market Share, 2019-2021
